Thursday, November 21

Tag: Vaccine

News

Mexico approves use of Chinese CanSino and Sinovac vaccines against COVID-19

The vaccines against COVID - 19, developed by the Chinese laboratories CanSino Biologics and Sinovac were approved by the Federal Commission for the Protection against Sanitary Risks of Mexico (Cofepris) for emergency use in people of 18 years or more. Hugo López-Gatell, Undersecretary of Prevention and Health Promotion explained that these vaccines have shown low efficacy compared to others, however, as more data accumulates and with the advancement of information it is possible that this changes and there is a higher estimate. Mexico is one of the countries where the Cansino vaccine is being tested. The 30 of October, the first doses of this vaccine arrived to carry out phase three of clinical trials in the country. The federal government plans to buy CanSino 35 millions of dos...
USA News

Johnson & Johnson requests FDA clearance for its COVID-19 vaccine

J&J Covid Vaccine - 26 requires a single dose. Photo: JUSTIN TALLIS / AFP / Getty Images A third coronavirus vaccine has applied for emergency use authorization from the Food and Drug Administration (FDA). Johnson & Johnson submitted its application on Thursday for authorization of its single dose COVID vaccine - 19. In a statement issued Thursday, the company said that if the emergency use permit is granted, its goal is to supply 100 million doses of vaccines in the first half of 2021 . Unlike Pfizer and Moderna, Johnson & Johnson's Janssen vaccine can be stored for at less three months to 36 - 46 degrees Fahrenheit, compatible with standard vaccine distribution channels, the company said. The vaccine has been shown to have a 66% effective overall in preventing COVID - 19 ...
News

Russian Sputnik V vaccine is 91.6% effective, says The Lancet medical journal

An interim analysis of data from the phase III covid vaccine trial - 19 from Russia (Sputnik V) suggests that a two-dose regimen offers an efficacy of 91 .6% against symptomatic disease; a protection that in older than 60 years is very similar and rises to 91. 8%. Preliminary results, published in “The Lancet”, are based on analysis of data from almost 20, 000 participants, of which three quarters parts received the vaccine and a quarter received placebo. The trial included 2. 144 participants older than 60 years and the efficacy of the vaccine was 91, 8% in this group: the vaccine was well tolerated and the safety data of 1. 369 of these older adults revealed that the most common adverse effects were flu symptoms and local reaction. These coincide with the majority of adverse ef...
News

South African variant of coronavirus detected in United States

Covid vaccine vials - 19 from the biotechnology company Novavax. Photo: JUSTIN TALLIS / AFP / Getty Images A highly communicable coronavirus variant first identified in South Africa was reported Thursday in the United States, hours before Maryland biotech company Novavax announced that its coronavirus vaccine was highly effective in preventing COVID - 19, except against that variant . The information provided by the vaccine manufacturer Novavax on an initial analysis conducted in Great Britain found that the vaccine had an efficacy rate of nearly 80% in the Great Britain variant, but in a small assay done with the South African variant of coronavirus , the effectiveness rate dropped to just under 50%. The data surprised and disappointed scientists, who said that is the lat...
USA News

California Considers Prioritizing Age Over Other Factors To Get Coronavirus Vaccine

Vaccinate the entire population over 65 years in the golden state would take until June. Photo: Mario Tama / Getty Images Farmworker advocates, grocery store teacher teachers and other essential workers are worried they will have to wait until this summer to get vaccinated against the coronavirus as California considers prioritizing older residents. State officials say the decision makes sense given that older people have a much higher rate of hospitalization and death from COVID - 19. However, it could take until June to vaccinate all Californians of 65 years or more, as reported Sunday Sacramento Bee . A vaccination you have only in Counting age could mean teachers and school staff wouldn't get vaccinated until next summer , says Debra Schade, member of the Solana Beach...
USA News

Mexico will adjust vaccination plan against COVID-19 due to reduction of Pfizer deliveries

The President of Mexico, Andrés Manuel López Obrador, affirmed that despite the reduction in the delivery of doses from the pharmaceutical company Pfizer, his government will finish vaccinating adults older than 60 years. “We are the first in Latin America in the application of vaccine and as explained here, by the end of March, we will finish vaccinating all adults older than 60 years and this, of According to scientists, it will allow us to reduce mortality by up to 80 percent. " Despite the decrease due to the circumstances that Pfizer presented us to a UN lawsuit, so that vaccines are available for countries that have less economic possibilities than us, still look at how we are doing, this too it has a lot to do with the organization, our government is organized, it is the organ...